Corient IA LLC

Position in GSK — GSK plc

CIK 2058426 MIAMI, FL

Position in GSK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$103,791

-$225,693 QoQ

Shares Held

1,980

-66.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#764

of 1,033 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Corient IA LLC holds $3,212,123 across 7 Drug Manufacturers - General names. GSK ranks #5 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,670	$2,003,048
2	GILD	Gilead Sciences, Inc.	3,540	$447,243
3	AMGN	Amgen Inc	890	$322,286
4	NVS	Novartis AG	1,030	$161,421
5	GSK	GSK plc This page	1,980	$103,791
6	SNY	Sanofi	2,120	$90,439
7	NVO	Novo Nordisk A S	1,750	$83,895

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$103,791	1,980	-66.8%	Shares	Sole	2026-08-12
2026-03-31	$329,484	5,970	0.0%	Shares	Sole	2026-05-14
2025-12-31	$292,768	5,970	-40.3%	Shares	Sole	2026-02-13
2025-09-30	$431,600	10,000	-33.3%	Shares	Sole	2025-11-12
2025-06-30	$576,000	15,000	0.0%	Shares	Sole	2025-08-14
2025-03-31	$581,100	15,000	—	Shares	Sole	2025-05-13
No filing history on record for this holder in this stock.